Loading…

Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B

To investigate the promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) on liver and thyroid carcinogenesis of rats at doses that cause maximal induction of hepatic CYP2B, 5-week-old male F344 rats were given either a single i.p. dose of 75 mg N-nitrosodiethylamine (NDEA)/kg bod...

Full description

Saved in:
Bibliographic Details
Published in:Carcinogenesis (New York) 1996-01, Vol.17 (1), p.37-43
Main Authors: Diwan, Bhalchandra A., Henneman, John R., Rice, Jerry M., Nims, Raymond W.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c428t-63a6575a9f4f2725254825ca5d11df60d46c8d6568834e72c7f5bdcb254626853
cites
container_end_page 43
container_issue 1
container_start_page 37
container_title Carcinogenesis (New York)
container_volume 17
creator Diwan, Bhalchandra A.
Henneman, John R.
Rice, Jerry M.
Nims, Raymond W.
description To investigate the promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) on liver and thyroid carcinogenesis of rats at doses that cause maximal induction of hepatic CYP2B, 5-week-old male F344 rats were given either a single i.p. dose of 75 mg N-nitrosodiethylamine (NDEA)/kg body wt in saline or saline alone. After 2 weeks the rats were fed control diet or a diet containing 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. phenobarbital (PB; a positive control group). A total of four sequential sacrifices (9, 30, 52 and 79 weeks of age) was performed. At 30 weeks the mean volume (mm3) of hepatocellular foci in NDEA-initiated rats exposed to either dose of TCPOBOP or to PB was significantly increased as compared with rats exposed to NDEA followed by control diet (P < 0.05). In addition, the volume percentage of liver occupied by foci was significantly greater in NDEA-initiated/1000 p.p.m. TCPOBOP-promoted rats as compared with rats exposed to NDEA alone (P < 0.05, n = 6). At 52 weeks of age the incidences (and multiplicities, in units of tumors per tumor-bearing rat) of hepatocellular adenomas were 0, 83 (2.6 ± 1.3), 100 (3.4 ± 2.1) or 67% (2.5 ± 1.9) in rats exposed to NEDA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively (n = 12). Hepatocellular carcinomas were found only in rats given 1000 p.p.m. TCPOBOP (17% incidence) or PB (8% incidence) following NDEA initiation. The incidences of thyroid follicular cell adenomas were 0, 17, 33 or 8% in rats exposed to NDEA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively. Between 53 and 79 weeks of age 38% of rats treated with NDEA alone developed multiple (1.5 ± 0.8) hepatocellular adenomas. This incidence was enhanced to 100% in rats exposed to NDEA followed by either 330 or 1000 p.p.m. TCPOBOP. Multiplicities of hepatocellular adenomas were also increased significantly (10.5 ± 3.9, 10.4 ± 7.0 and 10.1 ± 6.7 respectively) in rats promoted with 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB. None of the rats exposed to NDEA alone developed hepatocellular carcinomas, while multiple hepatocellular carcinomas occurred in 38% of the rats exposed to 330 p.p.m. and 78% of the rats given 1000 p.p.m. TCPOBOP following NDEA initiation. Thyroid follicular cell tumors occurred at 79 weeks in more than 40 and 50% incidences in rats exposed to NDEA followed by 330 or 1000 p.p.m. TCPOBOP respectively. Also, a significant decrease in serum levels of trii
doi_str_mv 10.1093/carcin/17.1.37
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17022055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17022055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-63a6575a9f4f2725254825ca5d11df60d46c8d6568834e72c7f5bdcb254626853</originalsourceid><addsrcrecordid>eNo9kUuLFDEUhYMoY8_o1p2QhYjCVE_eqVpqz0yPMKILBR9ISCUpO1qVtEkVdPk7_MGm6aZXCZzvnHO5F4BnGC0xauiV0cn4cIXlEi-pfAAWmAlUEVyjh2CBMKMVpZQ9Buc5_0IIC8qbM3BWc8ExZQvw7yZsdDBucGGEsYPjZk7RW6iDhRu31WM8FMSfLrjsM2xniC9Z1fr8nVSv6CWvrDebPqa4nZO3cx938-sfrQt_iwH6AJMeM9QjtDG7XPLL1-gpOzjonR90Xxg7mdHHsO9fff1I3j4BjzrdZ_f0-F6Az7c3n1Z31f2H9bvVm_vKMFKPlaBacMl107GOSMIJZzXhRnOLse0EskyY2gou6poyJ4mRHW-taQsniKg5vQAvD7nbFP9MLo9q8Nm4vtfBxSkrLBEhiO_B5QE0KeacXKe2qcyeZoWR2p9BHbZUHAorKovh-TF5agdnT_hx70V_cdR1NrrvUrmBzyeMNFKQZt9bHTCfR7c7yTr9VkJSydXdl29qjeo1k7fX6j39D30KoJk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17022055</pqid></control><display><type>article</type><title>Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B</title><source>Oxford Journals Online</source><creator>Diwan, Bhalchandra A. ; Henneman, John R. ; Rice, Jerry M. ; Nims, Raymond W.</creator><creatorcontrib>Diwan, Bhalchandra A. ; Henneman, John R. ; Rice, Jerry M. ; Nims, Raymond W.</creatorcontrib><description>To investigate the promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) on liver and thyroid carcinogenesis of rats at doses that cause maximal induction of hepatic CYP2B, 5-week-old male F344 rats were given either a single i.p. dose of 75 mg N-nitrosodiethylamine (NDEA)/kg body wt in saline or saline alone. After 2 weeks the rats were fed control diet or a diet containing 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. phenobarbital (PB; a positive control group). A total of four sequential sacrifices (9, 30, 52 and 79 weeks of age) was performed. At 30 weeks the mean volume (mm3) of hepatocellular foci in NDEA-initiated rats exposed to either dose of TCPOBOP or to PB was significantly increased as compared with rats exposed to NDEA followed by control diet (P &lt; 0.05). In addition, the volume percentage of liver occupied by foci was significantly greater in NDEA-initiated/1000 p.p.m. TCPOBOP-promoted rats as compared with rats exposed to NDEA alone (P &lt; 0.05, n = 6). At 52 weeks of age the incidences (and multiplicities, in units of tumors per tumor-bearing rat) of hepatocellular adenomas were 0, 83 (2.6 ± 1.3), 100 (3.4 ± 2.1) or 67% (2.5 ± 1.9) in rats exposed to NEDA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively (n = 12). Hepatocellular carcinomas were found only in rats given 1000 p.p.m. TCPOBOP (17% incidence) or PB (8% incidence) following NDEA initiation. The incidences of thyroid follicular cell adenomas were 0, 17, 33 or 8% in rats exposed to NDEA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively. Between 53 and 79 weeks of age 38% of rats treated with NDEA alone developed multiple (1.5 ± 0.8) hepatocellular adenomas. This incidence was enhanced to 100% in rats exposed to NDEA followed by either 330 or 1000 p.p.m. TCPOBOP. Multiplicities of hepatocellular adenomas were also increased significantly (10.5 ± 3.9, 10.4 ± 7.0 and 10.1 ± 6.7 respectively) in rats promoted with 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB. None of the rats exposed to NDEA alone developed hepatocellular carcinomas, while multiple hepatocellular carcinomas occurred in 38% of the rats exposed to 330 p.p.m. and 78% of the rats given 1000 p.p.m. TCPOBOP following NDEA initiation. Thyroid follicular cell tumors occurred at 79 weeks in more than 40 and 50% incidences in rats exposed to NDEA followed by 330 or 1000 p.p.m. TCPOBOP respectively. Also, a significant decrease in serum levels of triiodothyronine and thyroxine were observed in non-initiated 79-week-old rats fed 1000 p.p.m. TCPOBOP, compared with age-matched untreated controls (n = 6). Increases in hepatic CYPC2B-mediated benzyloxy-resorufin O-dealkylase activity detected in rats exposed to 330 and 1000 p.p.m. TCPOBOP for 2 or 23 weeks were similar in magnitude to those caused by 500 p.p.m. PB. Thus TCPOBOP at maximal CYP2B induction doses exhibits a strong promoting activity for both liver and thyroid of rats.</description><identifier>ISSN: 0143-3334</identifier><identifier>EISSN: 1460-2180</identifier><identifier>DOI: 10.1093/carcin/17.1.37</identifier><identifier>PMID: 8565134</identifier><identifier>CODEN: CRNGDP</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Animals ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; Carcinogens - toxicity ; Chemical agents ; Cytochrome P-450 Enzyme System - biosynthesis ; Cytochrome P-450 Enzyme System - drug effects ; Diethylnitrosamine ; Enzyme Induction - drug effects ; Liver Neoplasms, Experimental - chemically induced ; Male ; Medical sciences ; Precancerous Conditions - chemically induced ; Pyridines - toxicity ; Rats ; Rats, Inbred F344 ; Thyroid Hormones - blood ; Thyroid Neoplasms - chemically induced ; Tumors ; Weight Gain - drug effects</subject><ispartof>Carcinogenesis (New York), 1996-01, Vol.17 (1), p.37-43</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-63a6575a9f4f2725254825ca5d11df60d46c8d6568834e72c7f5bdcb254626853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2976295$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8565134$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diwan, Bhalchandra A.</creatorcontrib><creatorcontrib>Henneman, John R.</creatorcontrib><creatorcontrib>Rice, Jerry M.</creatorcontrib><creatorcontrib>Nims, Raymond W.</creatorcontrib><title>Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B</title><title>Carcinogenesis (New York)</title><addtitle>Carcinogenesis</addtitle><description>To investigate the promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) on liver and thyroid carcinogenesis of rats at doses that cause maximal induction of hepatic CYP2B, 5-week-old male F344 rats were given either a single i.p. dose of 75 mg N-nitrosodiethylamine (NDEA)/kg body wt in saline or saline alone. After 2 weeks the rats were fed control diet or a diet containing 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. phenobarbital (PB; a positive control group). A total of four sequential sacrifices (9, 30, 52 and 79 weeks of age) was performed. At 30 weeks the mean volume (mm3) of hepatocellular foci in NDEA-initiated rats exposed to either dose of TCPOBOP or to PB was significantly increased as compared with rats exposed to NDEA followed by control diet (P &lt; 0.05). In addition, the volume percentage of liver occupied by foci was significantly greater in NDEA-initiated/1000 p.p.m. TCPOBOP-promoted rats as compared with rats exposed to NDEA alone (P &lt; 0.05, n = 6). At 52 weeks of age the incidences (and multiplicities, in units of tumors per tumor-bearing rat) of hepatocellular adenomas were 0, 83 (2.6 ± 1.3), 100 (3.4 ± 2.1) or 67% (2.5 ± 1.9) in rats exposed to NEDA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively (n = 12). Hepatocellular carcinomas were found only in rats given 1000 p.p.m. TCPOBOP (17% incidence) or PB (8% incidence) following NDEA initiation. The incidences of thyroid follicular cell adenomas were 0, 17, 33 or 8% in rats exposed to NDEA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively. Between 53 and 79 weeks of age 38% of rats treated with NDEA alone developed multiple (1.5 ± 0.8) hepatocellular adenomas. This incidence was enhanced to 100% in rats exposed to NDEA followed by either 330 or 1000 p.p.m. TCPOBOP. Multiplicities of hepatocellular adenomas were also increased significantly (10.5 ± 3.9, 10.4 ± 7.0 and 10.1 ± 6.7 respectively) in rats promoted with 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB. None of the rats exposed to NDEA alone developed hepatocellular carcinomas, while multiple hepatocellular carcinomas occurred in 38% of the rats exposed to 330 p.p.m. and 78% of the rats given 1000 p.p.m. TCPOBOP following NDEA initiation. Thyroid follicular cell tumors occurred at 79 weeks in more than 40 and 50% incidences in rats exposed to NDEA followed by 330 or 1000 p.p.m. TCPOBOP respectively. Also, a significant decrease in serum levels of triiodothyronine and thyroxine were observed in non-initiated 79-week-old rats fed 1000 p.p.m. TCPOBOP, compared with age-matched untreated controls (n = 6). Increases in hepatic CYPC2B-mediated benzyloxy-resorufin O-dealkylase activity detected in rats exposed to 330 and 1000 p.p.m. TCPOBOP for 2 or 23 weeks were similar in magnitude to those caused by 500 p.p.m. PB. Thus TCPOBOP at maximal CYP2B induction doses exhibits a strong promoting activity for both liver and thyroid of rats.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Carcinogens - toxicity</subject><subject>Chemical agents</subject><subject>Cytochrome P-450 Enzyme System - biosynthesis</subject><subject>Cytochrome P-450 Enzyme System - drug effects</subject><subject>Diethylnitrosamine</subject><subject>Enzyme Induction - drug effects</subject><subject>Liver Neoplasms, Experimental - chemically induced</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Precancerous Conditions - chemically induced</subject><subject>Pyridines - toxicity</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Thyroid Hormones - blood</subject><subject>Thyroid Neoplasms - chemically induced</subject><subject>Tumors</subject><subject>Weight Gain - drug effects</subject><issn>0143-3334</issn><issn>1460-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNo9kUuLFDEUhYMoY8_o1p2QhYjCVE_eqVpqz0yPMKILBR9ISCUpO1qVtEkVdPk7_MGm6aZXCZzvnHO5F4BnGC0xauiV0cn4cIXlEi-pfAAWmAlUEVyjh2CBMKMVpZQ9Buc5_0IIC8qbM3BWc8ExZQvw7yZsdDBucGGEsYPjZk7RW6iDhRu31WM8FMSfLrjsM2xniC9Z1fr8nVSv6CWvrDebPqa4nZO3cx938-sfrQt_iwH6AJMeM9QjtDG7XPLL1-gpOzjonR90Xxg7mdHHsO9fff1I3j4BjzrdZ_f0-F6Az7c3n1Z31f2H9bvVm_vKMFKPlaBacMl107GOSMIJZzXhRnOLse0EskyY2gou6poyJ4mRHW-taQsniKg5vQAvD7nbFP9MLo9q8Nm4vtfBxSkrLBEhiO_B5QE0KeacXKe2qcyeZoWR2p9BHbZUHAorKovh-TF5agdnT_hx70V_cdR1NrrvUrmBzyeMNFKQZt9bHTCfR7c7yTr9VkJSydXdl29qjeo1k7fX6j39D30KoJk</recordid><startdate>199601</startdate><enddate>199601</enddate><creator>Diwan, Bhalchandra A.</creator><creator>Henneman, John R.</creator><creator>Rice, Jerry M.</creator><creator>Nims, Raymond W.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>199601</creationdate><title>Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B</title><author>Diwan, Bhalchandra A. ; Henneman, John R. ; Rice, Jerry M. ; Nims, Raymond W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-63a6575a9f4f2725254825ca5d11df60d46c8d6568834e72c7f5bdcb254626853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Carcinogens - toxicity</topic><topic>Chemical agents</topic><topic>Cytochrome P-450 Enzyme System - biosynthesis</topic><topic>Cytochrome P-450 Enzyme System - drug effects</topic><topic>Diethylnitrosamine</topic><topic>Enzyme Induction - drug effects</topic><topic>Liver Neoplasms, Experimental - chemically induced</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Precancerous Conditions - chemically induced</topic><topic>Pyridines - toxicity</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Thyroid Hormones - blood</topic><topic>Thyroid Neoplasms - chemically induced</topic><topic>Tumors</topic><topic>Weight Gain - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diwan, Bhalchandra A.</creatorcontrib><creatorcontrib>Henneman, John R.</creatorcontrib><creatorcontrib>Rice, Jerry M.</creatorcontrib><creatorcontrib>Nims, Raymond W.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Carcinogenesis (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diwan, Bhalchandra A.</au><au>Henneman, John R.</au><au>Rice, Jerry M.</au><au>Nims, Raymond W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B</atitle><jtitle>Carcinogenesis (New York)</jtitle><addtitle>Carcinogenesis</addtitle><date>1996-01</date><risdate>1996</risdate><volume>17</volume><issue>1</issue><spage>37</spage><epage>43</epage><pages>37-43</pages><issn>0143-3334</issn><eissn>1460-2180</eissn><coden>CRNGDP</coden><abstract>To investigate the promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) on liver and thyroid carcinogenesis of rats at doses that cause maximal induction of hepatic CYP2B, 5-week-old male F344 rats were given either a single i.p. dose of 75 mg N-nitrosodiethylamine (NDEA)/kg body wt in saline or saline alone. After 2 weeks the rats were fed control diet or a diet containing 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. phenobarbital (PB; a positive control group). A total of four sequential sacrifices (9, 30, 52 and 79 weeks of age) was performed. At 30 weeks the mean volume (mm3) of hepatocellular foci in NDEA-initiated rats exposed to either dose of TCPOBOP or to PB was significantly increased as compared with rats exposed to NDEA followed by control diet (P &lt; 0.05). In addition, the volume percentage of liver occupied by foci was significantly greater in NDEA-initiated/1000 p.p.m. TCPOBOP-promoted rats as compared with rats exposed to NDEA alone (P &lt; 0.05, n = 6). At 52 weeks of age the incidences (and multiplicities, in units of tumors per tumor-bearing rat) of hepatocellular adenomas were 0, 83 (2.6 ± 1.3), 100 (3.4 ± 2.1) or 67% (2.5 ± 1.9) in rats exposed to NEDA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively (n = 12). Hepatocellular carcinomas were found only in rats given 1000 p.p.m. TCPOBOP (17% incidence) or PB (8% incidence) following NDEA initiation. The incidences of thyroid follicular cell adenomas were 0, 17, 33 or 8% in rats exposed to NDEA alone or NDEA followed by 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB respectively. Between 53 and 79 weeks of age 38% of rats treated with NDEA alone developed multiple (1.5 ± 0.8) hepatocellular adenomas. This incidence was enhanced to 100% in rats exposed to NDEA followed by either 330 or 1000 p.p.m. TCPOBOP. Multiplicities of hepatocellular adenomas were also increased significantly (10.5 ± 3.9, 10.4 ± 7.0 and 10.1 ± 6.7 respectively) in rats promoted with 330 or 1000 p.p.m. TCPOBOP or 500 p.p.m. PB. None of the rats exposed to NDEA alone developed hepatocellular carcinomas, while multiple hepatocellular carcinomas occurred in 38% of the rats exposed to 330 p.p.m. and 78% of the rats given 1000 p.p.m. TCPOBOP following NDEA initiation. Thyroid follicular cell tumors occurred at 79 weeks in more than 40 and 50% incidences in rats exposed to NDEA followed by 330 or 1000 p.p.m. TCPOBOP respectively. Also, a significant decrease in serum levels of triiodothyronine and thyroxine were observed in non-initiated 79-week-old rats fed 1000 p.p.m. TCPOBOP, compared with age-matched untreated controls (n = 6). Increases in hepatic CYPC2B-mediated benzyloxy-resorufin O-dealkylase activity detected in rats exposed to 330 and 1000 p.p.m. TCPOBOP for 2 or 23 weeks were similar in magnitude to those caused by 500 p.p.m. PB. Thus TCPOBOP at maximal CYP2B induction doses exhibits a strong promoting activity for both liver and thyroid of rats.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>8565134</pmid><doi>10.1093/carcin/17.1.37</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0143-3334
ispartof Carcinogenesis (New York), 1996-01, Vol.17 (1), p.37-43
issn 0143-3334
1460-2180
language eng
recordid cdi_proquest_miscellaneous_17022055
source Oxford Journals Online
subjects Animals
Biological and medical sciences
Carcinogenesis, carcinogens and anticarcinogens
Carcinogens - toxicity
Chemical agents
Cytochrome P-450 Enzyme System - biosynthesis
Cytochrome P-450 Enzyme System - drug effects
Diethylnitrosamine
Enzyme Induction - drug effects
Liver Neoplasms, Experimental - chemically induced
Male
Medical sciences
Precancerous Conditions - chemically induced
Pyridines - toxicity
Rats
Rats, Inbred F344
Thyroid Hormones - blood
Thyroid Neoplasms - chemically induced
Tumors
Weight Gain - drug effects
title Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A18%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancement%20of%20thyroid%20and%20hepatocarcinogenesis%20by%201,4-bis%5B2-(3,5-dichloropyridyloxy)%5Dbenzene%20in%20rats%20at%20doses%20that%20cause%20maximal%20induction%20of%20CYP2B&rft.jtitle=Carcinogenesis%20(New%20York)&rft.au=Diwan,%20Bhalchandra%20A.&rft.date=1996-01&rft.volume=17&rft.issue=1&rft.spage=37&rft.epage=43&rft.pages=37-43&rft.issn=0143-3334&rft.eissn=1460-2180&rft.coden=CRNGDP&rft_id=info:doi/10.1093/carcin/17.1.37&rft_dat=%3Cproquest_cross%3E17022055%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c428t-63a6575a9f4f2725254825ca5d11df60d46c8d6568834e72c7f5bdcb254626853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17022055&rft_id=info:pmid/8565134&rfr_iscdi=true